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Summary
Objective: To examine the impact of prolonged TGF-â exposure on cartilage and ligamentous joint structures in vivo, to investigate
involvement of TGF-â in osteoarthritis pathology.
Methods: TGF-â was injected into murine knee joints once or repeatedly, whereafter articular cartilage proteoglycan (PG) synthesis and
content, and histological changes in knee joints were studied over a 2-month period.
Results: A single injection of TGF-â stimulated patellar cartilage PG synthesis for 3 weeks and PG content for 2 weeks. Triple TGF-â
injections prolonged the increase in PG content to 3 weeks. Patellar cartilage showed no histological abnormalities at 1 and 2 months after
the last injection. In contrast, 2 months after triple TGF-â injections the superficial layer of tibial cartilage still had an increased proteoglycan
content, while severe PG depletion was found in deeper layers of the posterior part of the lateral tibia in particular. Eventually, lesions
occurred at the level of the tide-mark, exactly the site where cartilage is torn off in experimental and spontaneous osteoarthritis in mice.
Additionally, multiple TGF-â injections induced formation of chondroid structures along the margins of articular cartilage. These chondroid
structures were transformed into osteophytes via endochondral ossification. Formation of chondroid tissue was also observed in collateral
ligaments.
Conclusion: Multiple intra-articular injections of TGF-â induce changes in articular cartilage and surrounding tissues that have strong
resemblance to features of experimental and spontaneous osteoarthritis in mice, suggesting a role for TGF-â in the OA process. © 2000
OsteoArthritis Research Society International
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In the search for mediators involved in osteoarthritis (OA)
pathology, transforming growth factor-â (TGF-â) has been
considered a likely candidate. TGF-â is a multipotent regu-
lator of cell growth and differentiation, and of extracellular
matrix production. Three different isoforms have been
found in mammalian species: TGF-â1, -â2, and -â3. The
mature TGF-â’s are all 25 kDa homodimers, with each
monomer consisting of 112 amino acids containing
nine cysteine residues. TGF-â is normally secreted as an
inactive high molecular weight complex which has to be
dissociated before activation. High levels of active TGF-â
have been found in synovial fluids of rheumatoid arthritis
and OA patients,1,2 indicating that this factor is produced
and activated during joint pathology. Enhanced expression
of TGF-â mRNA has been found in articular cartilage of the
STR/ort mouse which develops natural OA.3
In earlier studies4,5 we have shown that intra-articular
injections of TGF-â1 or -â2 stimulated articular cartilage
proteoglycan (PG) synthesis, counteracted suppression
of PG synthesis by interleukin-1, and accelerated PG
replenishment of depleted articular cartilage, suggesting25that TGF-â protects articular cartilage during pathology. On
the other hand, evidence is present that excessive/
prolonged exposure to this factor can have adverse effects.
TGF-â is a growth factor which is activated after tissue
damage, a condition which may apply to OA development
after ligament rupturing or cartilage lesions. Possibly,
TGF-â is involved in enhanced articular cartilage PG
synthesis as found in early experimental osteoarthritis6,7
and after a period of attempted repair it could be a trigger
for cartilage degeneration. Excessive levels of TGF-â also
induce fibrosis in joint tissues,4 as well as in kidney and
liver diseases and excessive scar formation in skin healing,
and this has been termed the dark side of tissue repair.8,9
In the present study we investigated changes in cartilage
and other joint structures, over a 2-month period after
single and repeated injections of TGF-â into the murine
knee joint, and compared the findings with spontaneous
OA lesions in aged mice.Materials and methodsReceived 25 January 1999; accepted 20 July 1999.
Address correspondence to: Henk van Beuningen, Department
of Rheumatology, University Hospital Nijmegen, Geert Grooteplein
Zuid 8, 6525 GA Nijmegen, The Netherlands.ANIMALS
Male C57Bl/10 mice aged 12 weeks or 18 months were
used. They were fed a standard diet and tap water ad
libitum.
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After anaesthetizing the mice with ether, 200 ng
recombinant human TGF-â1 (Genentech Inc., San
Francisco, CA, U.S.A.) dissolved in 6 ìl of physiological
saline (0.9% NaCl)+0.1% ultrapure bovine serum albumin
(Sigma, St Louis, MO, U.S.A.) was injected into the joint
cavity of the right knee once, or three times at alternate
days. Because of the short half-life of TGF-â in the joint, we
had to use high-dose injections. The 200 ng dose has been
shown effective in earlier in-vivo studies4,5 Simultaneously,
the contralateral joint received an equal volume of
saline+0.1% bovine serum albumin. To study whether the
effects of triple TGF-â injections can be augmented, 12
mice received six injections, at alternate days. Moreover, to
find out whether the joint would still react to TGF-â after
intense exposure, a group of six mice received, besides
these six injections, two extra injections 2 weeks after the
last of six injections. Experimental osteoarthritis was
induced by intra-articular injection of 10 units of highly
purified collagenase (type VII, Clostridium histolyticum,
Sigma, St Louis, MO, U.S.A) dissolved in 6 ìl physiological
10,11saline.DETERMINATION OF PATELLAR CARTILAGE PROTEOGLYCAN
SYNTHESIS
PG synthesis was measured ex vivo. Whole patellae,
with a standard amount of surrounding tissue, were
dissected from the knee joints. Patellae were then pulse-
labeled (2 hours at 37°C) with 35S-sulfate. Subsequently,
they were washed, fixed, decalcified, punched out of sur-
rounding tissue, and dissolved as described before.12 The
35S-content of each patella, which is a reliable measure of
patellar cartilage PG synthesis,13 was measured by liquid
scintillation counting.HISTOLOGY
Whole knee joints were dissected at different time points
after repeated intra-articular injection of 200 ng TGF-â and
processed as previously described.15 Semiserial frontal
sections (6 ìm) were mounted on gelatin-coated slides and
stained with hematoxylin/eosin or safranin O/fast green for
examination of cells and cartilage matrix, respectively. In
addition to TGF-â-induced changes, we also studied
histology of naturally occurring murine OA in joints of
18-month-old mice, and of experimentally induced OA in
collagenase-injected mice.DETERMINATION OF PATELLAR CARTILAGE PROTEOGLYCAN
CONTENT
Articular cartilage PG content is reflected by safranin O
staining intensity in histological sections. This was
measured, as described before,14 using an automated
image analysis system (VIDAS, Kontron Elektronik
GMBH). Microscopic images were recorded by a CDD
video camera (Sony) and stored and processed by a
personal computer. Optical density was measured by in-tegral measurement in a 20 ìm layer, along the cartilage
surface. The total zone of non-calcified cartilage was
approximately 30–40 ìm in width. Fast green staining was
neutralized by use of a green filter. Measurements were
corrected for lacunae. PG content in articular cartilage
of TGF-â injected joints was compared to content in
contralateral vehicle-injected joints.RNA ISOLATION AND RT-PCR
Total RNA was isolated from patellar cartilage and
synovial tissue by TRIzol extraction. RNA was directly
extracted from cartilage but synovial tissue was first
homogenized and then put in TRIzol reagent (Life
Technologies). Cartilage of 10 patellae was pooled and
synovium punches were taken from the same mice.
Before reverse transcription, the isolated RNA was
treated with DNAse I (Life Technologies). The reverse
transcription reaction was performed with Moloney murine
leukemia virus (M-MLV) reverse transcriptase (Life
Technologies) using an oligo(Dt)15 primer (Eurogentec,
Liege, Belgium). Amplification of DNA was accomplished
by using Taq DNA polymerase (Life Technologies) up to a
cycle number of 40. To determine the relative mRNA
levels, 5 ìl samples were taken at increasing cycle
numbers. The PCR products were electrophorised in
1.6% agarose gels containing ethidium bromide. The
cycle number at which the product was first detected on
the gel was taken as a measure for the amount of
specific mRNA present in the originally isolated RNA.
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
mRNA levels were used as an internal control. This
method was validated by van Meurs et al.16 All RT-PCR
reactions were performed in duplicate. The following
primers were used in the amplification reactions. To
detect GAPDH, the primers 5 ¢ -AACTCCCTCAAGATTGT
CAGCA-3¢ (upper) and 5¢ -TCCACCACCCTGTTGCTG
TA-3¢ were used (product 553 bp). Murine TGF-â1 prim-
ers were derived from Clontech (Palo Alto, CA, U.S.A.)
(product 525 bp), whereas murine TGF-â2 (product
489 bp) and -â3 (product 380 bp) were used as described
by Mulheron et al.17 For each time-point studied the RNA
extracts obtained from at least two different experiments
were analyzed.Statistical analysis
Differences between groups were tested using the
Student’s t-test. Differences were considered significant if
P<0.05.ResultsPROTEOGLYCAN SYNTHESIS
Intraarticular injection of 200 ng TGF-â stimulated articu-
lar cartilage PG synthesis after a lag time of about two
days. Maximum synthesis (>200%) was reached after 4
days. Even three weeks after a single injection PG
synthesis was still significantly increased (Fig. 1A). Stimu-
lation of PG synthesis was not further increased or pro-
longed if 200 ng TGF-â was injected three times, at
Osteoarthritis and Cartilage Vol. 8 No. 1 27alternate days, as compared with a single injection of
200 ng TGF-â (Fig. 1B).PROTEOGLYCAN CONTENT
Densitometric analysis of safranin O staining intensity in
histological sections showed that the GAG content in the
20 ìm superficial layer of the non-calcified articular
cartilage of the patella had significantly increased one week
after injection of 200 ng of TGF-â1 (Table I). This increase
was still present after two weeks (not shown), but after
three weeks it was lost. As compared with a single injection,
three injections of 200 ng TGF-â did not augment the
enhancing effect of TGF-â on patellar cartilage PG content
one week after the last injection, but the period of increased
PG content was prolonged with one extra week, to three
weeks after the last injection. One month after the lastinjection, the patellar cartilage PG content was not different
from normal, even if six injections were given instead of
three. Moreover, at this point of time, the patellar cartilage
showed no striking histologic changes. Besides patellar
cartilage, TGF-â temporarily increased the PG content in all
articular cartilage surfaces of the injected joint. In the tibia
the disturbance of PG content of the superficial cartilage
was even more prolonged, and was found over the whole
two-months period studied (Table I).Fig. 1. Long-lasting stimulation of PG synthesis in patellar cartilage
after one injection with 200 ng human rec TGF-â1 (A), or after
three such injections at alternate days (B). PG synthesis (35S-
sulfate incorporation) is expressed as percentage of that in the
contralateral, vehicle-injected joints. The experiment was per-
formed twice, with six patellae per experimental group each
time. Therefore the values represent the mean of 12 patellae.
*=significant increase.LESIONS IN TIBIAL CARTILAGE
Simultaneously with these supranormal GAG contents in
the 20 ìm superficial layer, focal areas with decreased
safranin O staining developed deeper in the cartilage of
load bearing areas of the lateral tibia (Fig. 2). These areas
with low chondrocyte density, and low extracellular matrix
PG content were found at sites just above the tide-mark. In
the adjacent superficial part of the cartilage, occasional
surface roughening and more often, clusters of chondro-
cytes with high pericellular PG concentration were found. In
sections of several knee joints, a crack along the tide-mark
was found at the site of the PG depletion (Fig. 2D).
Interestingly, in early stages of natural murine OA, in aging
mice, similar areas of PG depletion were found. In further
advanced stages of murine OA noncalcified cartilage was
lost, appearing to have been torn off from the tide-mark
(Fig. 2E).
TGF-â-induced focal PG loss was already present one
week after the last injection of TGF-â and the depleted
areas became larger with time. They were not found in
superficial frontal sections of the knee, but emerged in
deeper sections of the posterior part of the joint. In a small
percentage of control joints, some PG loss was found in the
same area, but the extent of spontaneous PG depletion
was marginal. No PG loss was ever found in patellar
cartilage. To study whether additional administration of
TGF-â further augmented the formation of TGF-â-inducedTable I
Increase of safranin O staining in superficial articular cartilage after
TGF-â injections
Group Day* Patella Lateral tibia
N†
Increase
(% of control) N†
Increase
(% of control)
3×vehicle D7 8 −11±9
1×TGF-â D7 8 19±10‡
3×TGF-â D7 12 21±6‡
1×TGF-â D21 6 7±6
3×TGF-â D21 6 11±5§
3×TGF-â D28 12 15±11 12 18±8§
6×TGF-â D28 12 18±18 12 11±5§
3×TGF-â D56 8 9±7 8 12±6§
Safranin O staining of articular cartilage in histological sections
was measured using an automated image analyzer. The increase
in staining intensity is expressed as percentage of the contra-
lateral, non-injected control knee joint.
*Days after the last injection.
†Number of joints measured: at least three sections of each joint
were measured.
Statistical significance of the TGF-â-induced increase was
tested using the Student’s t-test. §P<0.05, ‡P<0.01.
28 H. M. van Beuningen et al.: OA-like changes induced by TGF-âFig. 2. TGF-â induced changes in lateral tibia. Safranin O/fast green stained frontal sections of murine knee joint. (A) vehicle-injected control
(B) 7 days after the last of three TGF-â-injections areas with low PG content are present in the lateral tibia, and sometimes there is some
surface roughening (C) another TGF-â injected animal, showing abnormal distribution of chondrocytes, with high PG concentration around
superficial chondrocytes (D) crack at the level of the tide-mark in TGF-â-injected animal with lesion (E) for comparison, spontaneously
occurring crack at the level of the tide-mark in 18-month old mouse. M=meniscus, F=femur, T=tibia, AC=articular cartilage, JS=joint space.
Original magnification: ×200.lesions, experiments were performed in which six or eight
injections of TGF-â were given. However, these additional
injections did not affect number or size of the areas with PG
depletion (data not shown).OSTEOPHYTES
A single injection of 200 ng TGF-â induced transient
fibrosis in the synovium, but did not lead to changes in theappearance of articular cartilage and other joint structures.
In contrast, triple injections of 200 ng TGF-â induced
development of cartilage-like, PG-containing tissue, at the
margins of articular cartilage (Fig. 3B, C). These new
structures, which we named ‘chondrophytes’, seemed to
originate from the periosteum. Chondrophytes were not
found after a single TGF-â injection. A week after the last
injection, the new tissues had reached their maximum size
and thereafter they calcified via endochondral ossification
and developed into mature osteophytes, containing bone
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Two striking consequences of triple TGF-â injections
were synovial hyperplasia and thickening of ligaments and
tendons. Interestingly, another phenomenon also seen in
early osteoarthritis was found at day 28 in mice which
received six or eight TGF-â injections. Chondrogenesis
was observed in the collateral ligaments of these animals.
Large rounded cells with lacunae and pericellular PGs,
presumably fibrochondrocytes, were found in these sites
(Fig. 4B). For comparison, similar chondrogenesis (pre-
ceding partial ossification) was also found in collateral
ligaments of mice with collagenase-induced ligament dis-
ruption and subsequent instability-induced osteoarthritis
(Fig. 4C). In time, these chondroid structures also might
develop into bony structures, akin to ossicles present
in collateral ligaments of aged mice with spontaneous
osteoarthritis.TGF-â EFFECTS IN OLD MICE
In 18-month-old mice, TGF-â injections induced
stimulation of PG synthesis and development of osteo-
phytes and these effects were comparable to what was
seen in young adults (not shown). This indicates that in
old mice, the chondrocytes and the cells of the peri-
osteum still respond to TGF-â. Moreover, TGF-â injec-
tions appeared to induce development of cartilage-like
tissue on already existing bony structures (ossicles) in
ligaments of 18-month-old mice with spontaneous osteo-
arthritis (Fig. 4D). This suggests that TGF-â could beinvolved not only in induction, but also in outgrowth of
such structures.TGF-â AUTOINDUCTION
Since TGF-â appeared to have long-lasting effects on
articular cartilage, we estimated TGF-â autoinduction in
articular cartilage and neighbouring soft tissue. In patellar
cartilage, mRNA levels of TGF-â1, -â2, and -â3 were not
elevated at day 2 and day 8 after three intra-articular
injections with 200 ng TGF-â1. In contrast, in standardized
punches from neighbouring joint capsule, GAPDH-
corrected mRNA levels of all three isotypes of TGF-â
appeared to be elevated at these time points. In joint
capsule, intra-articularly injected TGF-â1 increased mRNA
of TGF-â1, -â2, and -â3 to levels that were approxi-
mately 16 times higher compared to normal joints, at
day 2 and 8. Figure 5 shows a characteristic result of
RT-PCR, illustrating TGF-â1 mRNA upregulation in
synovial tissue.Fig. 5. Semiquantitative TGF-â1 mRNA analysis in synovium and
patellar cartilage isolated from murine knee joints. Tissue was
taken 8 days after the last of three injections with 200 ng TGF-â1.
As a control, the vehicle-injected contralateral joints of the same
animals were used. Samples from the PCR reaction mixture where
taken with intervals of two cycli and run on an ethidium-stained
agarose gel. TGF-â1 mRNA levels were corrected for GAPDH
mRNA expression.Discussion
We examined the effects of prolonged TGF-â exposure
on articular cartilage and other joint structures in vivo, as a
way of investigating involvement of TGF-â in osteoarthritis
pathology. After multiple intra-articular injections of TGF-â,
we observed prolonged disturbances of articular cartilage
PG homeostasis. Both PG synthesis and content were
enhanced in all articular cartilage surfaces of the knee. In
patellar cartilage this was normalized in about one month,
but in tibial cartilage the PG content of the surface layer
was still enhanced at 2 months after the last injection.
Deeper in the tibial cartilage areas with PG loss were found
and in several animals cracks were observed at these sites.
Furthermore, we observed TGF-â-induced fibrosis, osteo-
phyte formation at specific sites, and development of
chondroid tissue in collateral ligaments. All TGF-â-induced
changes are very similar to changes that have been
reported in experimental OA in dogs,6,7 and changes we
observed in experimental OA in mice and in spontaneous
OA in old mice.
Already, one single injection of 200 ng TGF-â induced
long-lasting stimulation of patellar cartilage PG synthesis,
which started after a lagtime of about 2 days. This suggests
the involvement of changes in chondrocyte phenotype,
induction of second mediators, and/or TGF-â auto-
induction.18,19 TGF-â autoinduction at the mRNA level was
not detected in patellar cartilage, but strong upregulation of
all three TGF-â isotypes was observed in adjacent joint
capsule specimens during a period of at least 8 days after
the last of three intra-articular injections of TGF-â1. This
observation suggests that the effects of TGF-â1 injections
on articular cartilage can be increased and prolonged by
local TGF-â induction in neighbouring soft connective
tissue.
In addition to enhanced PG synthesis, the PG content in
the superficial layer of articular cartilage was also sig-
nificantly increased after TGF-â injection. PG content of
patellar cartilage was enhanced during 3 weeks after
the last of three TGF-â injections, and 1 week later, the
extracellular cartilage had normalized and also the
chondrocytes had a normal appearance. This is in contrast
to results from a study of Hulth and colleagues,20 whomarrow spaces (Fig. 3D). Even after prolonged exposure to
TGF-â, the periosteum remained responsive to TGF-â. This
was shown in a group of mice in which two weeks after the
last of six injections, two additional injections caused
renewed development of cartilage-like tissue on the
recently formed osteophytes (Fig. 3E).
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necrosis and decreased safranin O staining in the deeper
part of the cartilage. However, in tibial cartilage of TGF-â-
injected mice we noticed that in the superficial cartilage
the PG content was still enhanced even at two months.
Interestingly, in deeper cartilage layers, especially of the
lateral tibia, focal PG loss occurred in an area just above
the tide-mark, in the posterior part of the joint. In control
knees we sometimes observed areas with PG loss in the
same region, but these were much smaller. Therefore, we
postulate that TGF-â accelerates the pre-osteoarthritic
changes in murine articular cartilage. For development of
fullblown murine OA pathology, either more time is needed,
or additional factors are involved, like mechanical overload,
joint instability or local generation of other cytokines/growth
factors.
TGF-â-induced focal PG depletion was an unexpected
finding. TGF-â is known as a stimulator of extracellular
matrix production, an inhibitor of protease release and an
upregulator of TIMP expression, all fitting with a controling
role in further tissue damage. However, TGF-â has recently
been shown to be a potent inducer of MMP-13,21 an
enzyme involved in the pathophysiology of human OA.21–23
Intriguingly TGF-â-induced expression of MMP-13 was
mainly found in deeper layers of cartilage, fully in line with
our finding of characteristic localization of lesions in the
tibial plateau after TGF-â overexposure. It is therefore
tempting to speculate that TGF-â induces excessive
protease activation at defined, vulnerable sites in the
cartilage, and we are in the process of identifying local
enzyme levels with in-situ hybridization and cartilage
neoepitope immunohistochemistry.
Cracks at the level of the tide-mark were found in
several TGF-â-injected joints. Interestingly, spontaneous
development of clefts at the level of the lateral tibial
tide-mark in C57 black mice, genetically predisposed to
develop OA, has been reported.24 In late stages of both
natural and experimental murine OA, we noticed that tibial
noncalcified cartilage was either still present or had dis-
appeared completely, suggesting that tearing off at the
level of the tidemark is a characteristic feature of murine
OA. Probably focal cartilage degeneration plays a role
also in the mouse OA process. In the literature, areas of
PG loss in early stages of experimental OA models in
mice, leading to fissuring at later time points have been
described.11,25,26
TGF-â injections into murine knee joints not only affected
articular cartilage, but also stimulated periosteum to form
new cartilaginous structures, socalled chondrophytes. Pre-
vious studies have demonstrated that TGF-â can induce
cartilage and bone formation when it is applied to periosteal
cells in vitro and in vivo.5,27,28 In the underlying study we
showed that these early cartilage-like structures develop
into osteophytes and fuse with the original bone later on.
Like in experimental arthritis and spontaneous and exper-
imental osteoarthritis,5,11 these osteophytes were found
mainly along the margins of articular cartilage and at
insertion sites of ligaments.
BMP-2 is also a major inducer of cartilaginous outgrowth
after injection into the murine knee joint.29,30 However, the
characteristics of these outgrowths are quite different from
the ones induced with TGF-â, and the latter ones are much
more close to events found in spontaneous or experimen-
tally induced murine OA. It is clear from our recent studies
that another anabolic factor, IGF-1, is not capable of
induction of osteophytes after repeated intraarticular
injections (unpublished observations).Furthermore, we found effects of TGF-â on soft con-
nective tissues. Besides the thickening of synovium and
ligaments that was found after triple injections, develop-
ment of chondroid tissue in ligaments was seen after six or
eight injections of TGF-â. This is in line with studies
describing TGF-â-induced proliferation and matrix syn-
thesis by ligament fibroblasts.31,32 Also, TGF-â involve-
ment in ossification of ligaments in humans has been
suggested.33
There is ample evidence from experimental OA that the
early stage is characterized by enhanced chondrocyte
synthetic activity and hypertrophy. The latter would fit with
excessive growth factor stimulation and it is apparent
from our studies that TGF-â may be a likely candidate.
OA can develop after cartilage injury or ligament disrup-
tion and both of these conditions give rise to TGF-â
activation, probably in an attempt to reduce further
destruction and to promote repair. However, when con-
ditions develop where there is failure in attempted repair,
which is the case with ruptured ligaments or unrepairable
cartilage lesions, prolonged TGF-â activation is a likely
event. As illustrated by our study, prolonged exposure of
the joint to TGF-â eventually leads to OA-like events.
Apart from excessive local growth factor activation, it is
recently demonstrated that a failure in TGF-â receptor
activation may also give rise to OA-like lesions.34
Although this may seem contradictory to our findings, it is
reasonable to suggest that both a lack of an essential
repair factor as well as its prolonged overexpression may
cause joint pathology.
We conclude that multiple injections of TGF-â into the
murine knee joint induce OA-like changes in articular
cartilage and surrounding tissues, suggesting a patho-
genic role for excessive local TGF-â production in
osteoarthritis.References
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